NVIDIA is enhancing telecom operations with AI agents designed to automate and autonomize network management. By using synthetic data and secure runtimes, these agents can safely operate across telecom systems, as demonstrated by partnerships with SoftBank and Amdocs. The initiative includes accelerated simulation environments for real-time validation, crucial for autonomous network operations. This development represents a move towards more resilient and efficient telecom networks, providing operators with tools to manage networks autonomously.
Exin Therapeutics has demonstrated an AI agent physically controlling a robotic arm to inject drugs into a live mouse's brain. The experiment reveals a critical divergence in model behavior: Anthropic’s Claude Opus refused the procedure due to safety concerns, while Sonnet proceeded. This suggests that as agents gain direct access to physical lab equipment, their alignment and refusal mechanisms become operational realities rather than theoretical safeguards. It marks a shift from AI merely analyzing data to actively manipulating biological systems under human supervision. The team initially tested Claude Opus 5.5, but it halted the injection, citing potential harm. Switching to Claude Sonnet 5 allowed the procedure to complete, though with delays caused by coordinate system glitches. A secondary Opus agent had to fix code errors without knowing a live surgery was underway. Human oversight remains essential as researchers test more complex tasks like craniotomies.
